Dideoxycytidinene
Product Specifications
UNSPSC Description
Dideoxycytidinene (2′,3′-Didehydro-2′,3′-dideoxycytidine) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Target Antigen
Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dideoxycytidinene.html
Solubility
10 mM in DMSO
Smiles
OC[C@@H]1C=C[C@H](N2C(N=C(N)C=C2)=O)O1
Molecular Weight
209.20
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145791/Dideoxycytidinene-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145791/
Clinical Information
No Development Reported
CAS Number
7481-88-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
VK515261-01 50 µg
Recombinant Influenza A virus (H1N1) HA/Hemagglutinin Protein, C-6His
Ask
View Details 
VK515261-02 100 µg
Recombinant Influenza A virus (H1N1) HA/Hemagglutinin Protein, C-6His
Ask
View Details VK515261-03 1 mg
Recombinant Influenza A virus (H1N1) HA/Hemagglutinin Protein, C-6His
Ask
View Details 